Drug Pricing

This session offers new policy ideas for controlling drug prices. The proposals will be based on deliberations by NASHP’s Pharmacy Cost Work Group, the group who developed the “Call to Action” on drug prices in 2016. Since then, other policies have emerged, including new strategies for regulating pharmacy benefit managers, leveraging state purchasing power, and […]

Read More
  • State Health Policy Blog

    A New State Tool to Manage Drug Costs: Experts Share Insights into Outcome-Based Contracts for Medicaid Pharmacy Claims

    Colorado and Michigan have joined Oklahoma to become the nation’s pioneering states with approved State Plan Amendments (SPAs) that enable Medicaid alternative payment models (APMs) for prescription drugs in the form of outcome-based contracts with pharmaceutical manufacturers. In early May, state experts from Oklahoma, Colorado, and Michigan shared their experiences implementing their APMs during a […]

    Read More
  • State Health Policy Blog

    State Legislatures Examine Proposals to Curb Rx Drug Costs

    Recent legislative committee hearings in Maryland, Florida, and Illinois provide a national snapshot of states’ diverse and innovative proposals to reign in drug costs. Maryland’s drug affordability review board: Earlier this month, Maryland’s House Health and Government Operations Committee and Senate Finance Committee held lengthy hearings on an innovative bill that creates a state prescription […]

    Read More
  • Comparison of Bills Creating State Prescription Drug Affordability Review Boards

    A growing number of states are considering legislation to create prescription drug affordability review boards during the 2019 session. These boards would enable states to set “allowable rates” for certain high-cost drugs identified by the board, similar to the approach states use to regulate utilities or insurance premiums. NASHP released drug affordability review board model […]

    Read More
  • State Health Policy Blog

    Montana Explores a New Approach to Regulating Pharmacy Benefit Managers

    State legislatures across the country continue efforts to address the opaque business practices of pharmacy benefit managers (PBMs) to protect consumers and lower prescription drug prices. Montana is taking a new approach by leveraging its insurance department’s regulatory authority over insurance carriers by proposing a bill that tasks insurers with responsibility for overseeing that PBMs […]

    Read More
  • State Health Policy Blog

    Annual Federal Insurance Rule Includes Proposals to Address Prescription Drug Cost

    The Trump Administration’s effort to address drug prices surfaced unexpectedly in the Department of Health and Human Services (HHS)’s recently issued proposed annual rule that regulates state health insurance markets, including coverage sold through the Affordable Care Act (ACA) marketplaces. The proposal encourages the use of generic drugs over brand-name drugs by both health plans and enrollees […]

    Read More
  • State Health Policy Blog
    As Drug Prices Rise, Oklahoma’s Medicaid Agency Advances Alternative Payment Models

    As Drug Prices Rise, Oklahoma’s Medicaid Agency Advances Alternative Payment Models

    Escalating drug prices are forcing state Medicaid agencies to explore new payment models. According to Burl Beasley, director of Pharmacy Services for Oklahoma’s Medicaid program, older Medicaid payment strategies, such as negotiating enhanced rebates and multi-state purchase agreements, are not keeping pace with rising drug expenditures. Beasley cited the strain prescription drug costs were putting […]

    Read More
    December 17, 2018 | Filed under: Drug Pricing, Front Page, State Health Policy Blog

  • State Health Policy Blog
    States Take Administrative Actions to Curb Medicaid Drug Costs

    States Take Administrative Actions to Curb Medicaid Drug Costs

    During the 2018 legislative session, 28 states passed 45 laws to curb the rising cost of prescription drugs. In addition to legislative solutions, states are taking administrative action to better manage state spending on Medicaid pharmacy benefits. Ohio, West Virginia, and Vermont offer examples of states taking innovative administrative approaches to rein in drug costs. […]

    Read More
  • State Health Policy Blog
    Oklahoma Signs the Nation’s First State Medicaid Value-Based Contracts for Rx Drugs

    Oklahoma Signs the Nation’s First State Medicaid Value-Based Contracts for Rx Drugs

    On the heels of Oklahoma’s first-in-the-nation, value-based purchasing deal to improve adherence to an antipsychotic drug, the state’s Medicaid agency just signed its second value-based contract for a prescription drug used to treat serious bacterial skin infections. While several private insurers have initiated value-based contracting, which links payments to a drug’s effectiveness and outcome, Oklahoma […]

    Read More
  • NASHP Issues RFP for Partner to Help States Develop a Drug Cost Transparency Database

    NASHP Issues RFP for Partner to Help States Develop a Drug Cost Transparency Database

    NASHP’s Center for State Rx Drug Pricing seeks a partner to provide technical and strategic expertise to help a workgroup of state officials from California, Nevada, Oregon, Connecticut, and Vermont implement their drug cost transparency laws and help Maine and New Hampshire develop transparency programs as mandated by recent legislation. This work will help all […]

    Read More
    September 18, 2018 | Filed under: Drug Pricing, Featured-Rx, Front Page, Front Page-Rx, Transparency